Halozyme Therapeutics, Inc. -: automated data watch file
Automated data watch file for Halozyme Therapeutics, Inc. - (NASDAQ:HALO): balance-sheet, earnings, ownership and market-behaviour screens generated by Falling Shares Intelligence from public data. Not editor-reviewed; not investment advice.
| Security | NASDAQ:HALO |
|---|---|
| Currency | USD |
| Last price | $103.63 |
| 1-day move | -15.72% |
| 52-week range | $61.23 - $134 |
| From 52-week high | -22.70% |
| Volume vs average | 2.7x |
| Risk score | 59/100 (HIGH) |
| Market cap | $11.81B |
Method: Falling Shares Intelligence scores price stress (one-day fall, drawdown from the 52-week high, new lows) and volume anomalies against each security's own history. Scores are analytical indicators, not allegations of wrongdoing.
Halozyme Therapeutics, Inc. - company page
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com